A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction

Retrovirology

Volumn 5, Issue , 2008, Pages

  Willett, Brian J ^a   McMonagle, Elizabeth L ^a   Logan, Nicola ^a   Samman, Ayman ^a   Hosie, Margaret J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD134 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYSTEINE; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR; ENVELOPE PROTEIN, FELINE IMMUNODEFICIENCY VIRUS; GLYCOPROTEIN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS MUTATION; VIRUS STRAIN; AMINO ACID SUBSTITUTION; ANIMAL; CAT; CELL LINE; CHEMICAL STRUCTURE; GENETICS; GLYCOSYLATION; METABOLISM; MISSENSE MUTATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

FELINE IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS;

AMINO ACID SUBSTITUTION; ANIMALS; CATS; CELL LINE; GLYCOPROTEINS; GLYCOSYLATION; IMMUNODEFICIENCY VIRUS, FELINE; MODELS, MOLECULAR; MUTATION, MISSENSE; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CXCR4; RECEPTORS, OX40; VIRAL ENVELOPE PROTEINS; VIRUS ATTACHMENT;

EID: 53849098568     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-5-77     Document Type: Article

References (96)

1. Dalgleish AG Beverley PCL Clapham PR Crawford DH Greaves MF Weiss RA The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984, 312:763-767. 10.1038/312763a0 6096719
2. Klatzmann D Champagne E Chamaret S Guetard D Hercend T Gluckmann JC Montagnier L T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984, 312:767-768. 10.1038/312767a0 6083454
3. Berger EA Murphy PM Farber JM Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annual Review of Immunology 1999, 17:657-700. 10.1146/annurev.immunol.17.1.657 10358771
4. Clapham PR McKnight A Cell surface receptors, virus entry and tropism of primate lentiviruses J Gen Virol 2002, 83:1809-1829. 12124446
5. Roben P Moore JP Thali M Sodroski J Barbas CF III Burton DR Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1 J Virol 1994, 68:4821-4828. 236421 7518527
6. Li Y Migueles SA Welcher B Svehla K Phogat A Louder MK Wu X Shaw GM Connors M Wyatt RT Mascola JR Broad HIV-1 neutralization mediated by CD4-binding site antibodies Nat Med 2007, 13:1032-1034. 10.1038/nm1624 17721546
7. Kwong PD Wyatt R Robinson J Sweet RW Sodroski J Hendrickson WA Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody Nature 1998, 393:648-659. 10.1038/ 31405 9641677
8. Wyatt R Kwong PD Desjardins E Sweet RW Robinson J Hendrickson WA Sodroski JG The antigenic structure of the HIV gp120 envelope glycoprotein Nature 1998, 393:705-711. 10.1038/31514 9641684
9. Kwong PD Doyle ML Casper DJ Cicala C Leavitt SA Majeed S Steenbeke TD Venturi M Chaiken I Fung M Katinger H Parren PW Robinson J Van Ryk D Wang L Burton DR Freire E Wyatt R Sodroski J Hendrickson WA Arthos J HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites Nature 2002, 420:678-682. 10.1038/ nature01188 12478295
10. Decker JM Bibollet-Ruche F Wei X Wang S Levy DN Wang W Delaporte E Peeters M Derdeyn CA Allen S Hunter E Saag MS Hoxie JA Hahn BH Kwong PD Robinson JE Shaw GM Antigenic conservation and immunogenicity of the HIV coreceptor binding site J Exp Med 2005, 201:1407-1419. 2213183 15867093 10.1084/jem.20042510
11. Kolchinsky P Kiprilov E Sodroski J Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants J Virol 2001, 75:2041-2050. 114788 11160708 10.1128/JVI.75.5.2041-2050.2001
12. Kolchinsky P Kiprilov E Bartley P Rubinstein R Sodroski J Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops J Virol 2001, 75:3435-3443, 114136 11238869 10.1128/ JVI.75.7.3435-3443.2001
13. Endres MJ Clapham PR Marsh M Ahuja M Turner JD McKnight A Thomas JF Stoebenau-Haggarty B Choe S Vance PJ Wells TNC Power CA Sutterwala SS Doms RW Landau NR Hoxie JA CD4-independent infection by HIV-2 is mediated by fusin. Cell 1996, 87:745-756. 10.1016/S0092-8674(00)81393-8 8929542
14. Bhattacharya J Peters PJ Clapham PR CD4-independent infection of HIV and SIV: Implications for envelope conformation and cell tropism in vivo AIDS 2003, 17(Suppl 4):S35-S43. 10.1097/00002030-200317004-00004 15080178
15. Kolchinsky P Mirzabekov T Farzan M Kiprilov E Cayabyab M Mooney LJ Choe H Sodroski J Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication J Virol 1999, 73:8120-8126. 112828 10482561
16. Hoffman TL LaBranche CC Zhang W Canziani G Robinson J Chaiken I Hoxie JA Doms RW Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein Proc Natl Acad Sci U S A 1999, 96:6359-6364. 26886 10339592 10.1073/pnas.96.11.6359
17. Edwards TG Hoffman TL Baribaud F Wyss S LaBranche CC Romano J Adkinson J Sharron M Hoxie JA Doms RW Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein J Virol 2001, 75:5230-5239. 114929 11333905 10.1128/JVI.75.11.5230-5239.2001
18. Henderson GJ Hoffman NG Ping LH Fiscus SA Hoffman IF Kitrinos KM Banda T Martinson FE Kazembe PN Chilongozi DA Cohen MS Swanstrom R HIV-1 populations in blood and breast milk are similar Virology 2004, 330:295-303. 10.1016/j.virol.2004.09.004 15527854
19. Thomas ER Shotton C Weiss RA Clapham PR McKnight A CD4-dependent and CD4-independent HIV-2: Consequences for neutralization AIDS 2003, 17:291-300. 10.1097/00002030-200302140-00002 12556682
20. Edinger AL Mankowski JL Doranz BJ Margulies BJ Lee B Rucker J Sharron M Hoffman TL Berson JF Zink MC Hirsch VM Clements JE Doms RW CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain Proc Natl Acad Sci U S A 1997, 94:14742-14747. 25107 9405683 10.1073/ pnas.94.26.14742
21. Martin-Garcia J Cao W Varela-Rohena A Plassmeyer ML Gonzalez-Scarano F HIV-1 tropism for the central nervous system: Brain-derived envelope glycoproteins with lower CD4 dependence and reduced sensitivity to a fusion inhibitor Virology 2006, 346:169-179. 10.1016/j.virol.2005.10.031 16309726
22. Martin J LaBranche CC Gonzalez-Scarano F Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate J Virol 2001 75 3568 3580 114848 11264346 10.1128/JVI.75.8.3568-3580.2001
23. McKnight A Clapham PR Immune escape and tropism of HIV Trends Microbiol 1995, 3:356-361. 10.1016/S0966-842X(00)88975-1 8520889
24. McKnight A Weiss RA Shotton C Takeuchi Y Hoshino H Clapham PR Change in tropism upon immune escape by human immunodeficiency virus J Virol 1995, 69:3167-3170. 189019 7707545
25. Stamatatos L Cheng-Mayer C An envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades J Virol 1998, 72:7840-7845. 110102 9733820
26. Puffer BA Pohlmann S Edinger AL Carlin D Sanchez MD Reitter J Watry DD Fox HS Desrosiers RC Doms RW CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity J Virol 2002, 76:2595-2605. 135960 11861825 10.1128/JVI.76.6.2595-2605.2002
27. Shimojima M Miyazawa T Ikeda Y McMonagle EL Haining H Akashi H Takeuchi Y Hosie MJ Willett BJ Use of CD134 as a primary receptor by the feline immunodeficiency virus Science 2004, 303:1192-1195. 10.1126/ science.1092124 14976315
28. Willett BJ McMonagle EL logan N Spiller OB Schneider P Hosie MJ Probing the interaction between the feline immunodeficiency virus and CD134 using a novel monoclonal antibody 7D6 and CD134L (OX40L) J Virol 2007, 81:9665-9679. 2045395 17609274 10.1128/JVI.01020-07
29. de Parseval A Chatterji U Sun P Elder JH Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor Proc Natl Acad Sci U S A 2004, 101:13044-13049. 516514 15326292 10.1073/ pnas.0404006101
30. Willett BJ McMonagle EL Ridha S Hosie MJ Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus (FIV). J Virol 2006, 80:3386-3394. 1440405 16537606 10.1128/JVI.80.7.3386-3394.2006
31. Talbott RL Sparger EE Lovelace KM Fitch WM Pedersen NC Luciw PA Elder JH Nucleotide-sequence and genomic organization of feline immunodeficiency virus Proc Natl Acad Sci U S A 1989, 86:5743-5747. 297706 2762293 10.1073/pnas.86.15.5743
32. Olmsted RA Barnes AK Yamamoto JK Hirsch VM Purcell RH Johnson PR Molecular cloning of feline immunodeficiency virus. Proc Natl Acad Sci USA 1989, 86:2448-2452. 286930 2928341 10.1073/pnas.86.7.2448
33. Willett BJ Hosie MJ Neil JC Turner JD Hoxie JA Common mechanism of infection by lentiviruses. Nature 1997, 385:587. 10.1038/385587a0 9024654
34. Willett BJ Picard L Hosie MJ Turner JD Adema K Clapham PR Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J Virol 1997 71 6407 6415 191914 9261358
35. de Parseval A Ngo S Sun P Elder JH Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication J Virol 2004, 78:9132-9143. 506950 15308709 10.1128/JVI.78.17.9132-9143.2004
36. Pedersen NC Ho EW Brown ML Yamamoto JK Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency syndrome. Science 1987, 235:790-793. 10.1126/science.3643650 3643650
37. Yamamoto JK Hohdatsu T Olmsted RA Pu R Louie H Zochlinski HA Acevedo V Johnson HM Soulds GA Gardner MB Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J Virol 1993, 67:601-605. 237403 8380095
38. Yamamoto JK Okuda T Ackley CD Louie H Pembroke E Zochlinski H Munn RJ Gardner MB Experimental vaccine protection against feline immunodeficiency virus Aids Res Hum Retroviruses 1991, 7:911-921. 1662057
39. Hosie MJ Flynn JN Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection. J Virol 1996, 70:7561-7568. 190824 8892875
40. Flynn JN Keating P Hosie MJ Mackett M Stephens EB Beatty JA Neil JC Jarrett O Env-specific cytotoxic T lymphocytes predominate in cats protected from feline immunodeficiency virus infection by vaccination. J Immunol 1996, 157(8):3658-3665. 8871667
41. Hosie M Osborne R Yamamoto JK Neil JC Jarrett O Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J Virol 1995, 69:1253-1255. 188698 7815500
42. Flynn JN Beatty JA Cannon CA Stephens EB Hosie MJ Neil JC Jarrett O Involvement of gag-specific and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. Aids Res Hum Retroviruses 1995, 11:1107-1113. 8554908
43. Dunham SP Bruce J MacKay S Golder M Jarrett O Neil JC Limited efficacy of an inactivated feline immunodeficiency virus vaccine Vet Rec 2006, 158:561-562. 16632531
44. Hosie MJ Beatty JA Vaccine protection against feline immunodeficiency virus: Setting the challenge Aust Vet J 2007, 85:5-12. 10.1111/ j.1751-0813.2006.00071.x 17300445
45. Hosie MJ Dunsford TD de Ronde A Willett BJ Cannon CA Neil JC Jarrett O Suppression of virus burden by immunisation with feline immunodeficiency virus Env protein. Vaccine 1996 14 405 411 10.1016/0264-410X(95)00193-5 8735552
46. Hosie MJ Osborne R Reid G Neil JC Jarrett O Enhancement after feline immunodeficiency virus vaccination. Vet Immunol Immunopathol 1992, 35:191-198. 10.1016/0165-2427(92)90131-9 1337397
47. Karlas JA Siebelink KH Peer MA Huisman W Cuisinier AM Rimmelzwaan GF Osterhaus AD Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection J Gen Virol 1999, 80(Pt 3):761-765. 10092017
48. Karlas JA Siebelink KH Peer MA Huisman W Rimmelzwaan GF Osterhaus AD Accelerated viraemia in cats vaccinated with fixed autologous FIV-infected cells Vet Immunol Immunopathol 1998, 65:353-365. 10.1016/ S0165-2427(98)00166-4 9839884
49. Osterhaus AD Tijhaar E Huisman RC Huisman W Darby IH Francis MJ Rimmelzwaan GF Siebelink KH Accelerated viremia in cats vaccinated with recombinant vaccinia virus expressing envelope glycoprotein of feline immunodeficiency virus Aids Res Hum Retroviruses 1996, 12:437-441. 8882329
50. Siebelink KHJ Tijhaar E Huisman RC Huisman W de Ronde A Darby IH Francis MJ Rimmelzwaan GF Osterhaus ADME Enhancement of feline immunodeficiency virus infection after immunisation with envelope glycoprotein subunit vaccines. J Virol 1995, 69:3704-3711. 189086 7745719
51. Giannecchini S Isola P Sichi O Matteucci D Pistello M Zaccaro L Del Mauro D Bendinelli M AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: Failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts J Virol 2002, 76:6882-6892. 136316 12072489 10.1128/JVI.76.14.6882-6892.2002
52. Koito A Stamatatos L Cheng-Mayer C Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type 1 envelope gp120 Virology 1995, 206:878-884. 10.1006/viro.1995.1010 7856100
53. Koito A Harrowe G Levy JA Cheng-Mayer C Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization J Virol 1994, 68:2253-2259. 236701 8139010
54. Toohey K Wehrly K Nishio J Perryman S Chesebro B Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread Virology 1995, 213:70-79. 10.1006/ viro.1995.1547 7483281
55. Wyatt R Moore J Accola M Desjardin E Robinson J Sodroski J Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding J Virol 1995, 69:5723-5733. 189432 7543586
56. Sullivan N Thali M Furman C Ho DD Sodroski J Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody J Virol 1993, 67:3674-3679. 237724 8497077
57. Groenink M Fouchier RA Broersen S Baker CH Koot M Van't Wout AB Huisman HG Miedema F Tersmette M Schuitemaker H Relation of phenotype evolution of HIV-1 to envelope V2 configuration Science 1993, 260:1513-1516. 10.1126/science.8502996 8502996
58. Hosie MJ Willett BJ Klein D Dunsford TH Cannon C Shimojima M Neil JC Jarrett O Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence. J Virol 2002, 76:6062-6072. 136200 12021339 10.1128/ JVI.76.12.6062-6072.2002
59. Miyazawa TM Furuya T Itagaki S Tohya Y Takahashi E Mikami T Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus Arch Virol 1989, 108:131-135. 10.1007/BF01313750 2480760
60. Cheney CM Rojko JL Kociba GJ Wellman ML Di Bartola SP Rezanka LJ Forman L Mathes LE A feline large granular lymphoma and its derived cell line In Vitro Cell Dev Biol 1990 26 455 463 10.1007/BF02624087 2161827
61. Laemmli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 1970, 227:680-685. 10.1038/227680a0 5432063
62. Hosie MJ Jarrett O Serological responses of cats to feline immunodeficiency virus. AIDS 1990, 4:215-220. 10.1097/ 00002030-199003000-00006 2161670
63. Willett BJ McMonagle EL Bonci F Pistello M Hosie MJ Mapping the domains of CD134 as a functional receptor for feline immunodeficiency virus J Virol 2006, 80:7744-7747. 1563730 16840353 10.1128/JVI.00722-06
64. Donzella GA Schols D Lin SW Este JA Nagashima KA Maddon PJ Allaway GP Sakmar TP Henson G DeClercq E Moore JP AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co- receptor. Nat Med 1998, 4:72-77. 10.1038/nm0198-072 9427609
65. Egberink HF De Clerq E Van Vliet AL Balzarini J Bridger GJ Henson G Horzinek MC Schols D Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication. J Virol 1999, 73:6346-6352. 112713 10400726
66. Willett BJ Hosie MJ The role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus Molecular Membrane Biology 1999, 16:67-72. 10.1080/096876899294779 10332739
67. Spiller OB Mark L Blue CE Proctor DG Aitken JA Blom AM Blackbourn DJ Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding J Virol 2006, 80:4068-4078. 1440425 16571823 10.1128/JVI.80.8.4068-4078.2006
68. Yamamoto JK Ackley CD Zochlinski H Louie H Pembroke E Torten M Hansen H Munn R Okuda T Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency viruses: importance for diagnostic reagents and vaccines Intervirology 1991, 32:361-375. 1657826
69. Phillips TR Talbott RL Lamont C Muir S Lovelace K Elder JH Comparison of two host cell range variants of feline immunodeficiency virus. J Virol 1990, 64:4605-4613. 247944 1697907
70. Altschul SF Madden TL Schaffer AA Zhang J Zhang Z Miller W Lipman DJ Gapped BLAST and PSI-BLAST: A new generation of protein database search programs Nucleic Acids Res 1997, 25:3389-3402. 146917 9254694 10.1093/ nar/25.17.3389
71. Kakinuma S Motokawa K Hohdatsu T Yamamoto JK Koyama H Hashimoto H Nucleotide sequence of feline immunodeficiency virus: Classification of Japanese isolates into two subtypes which are distinct from non-Japanese subtypes J Virol 1995, 69:3639-3646. 189079 7745712
72. Pu R Coleman J Coisman J Sato E Tanabe T Arai M Yamamoto JK Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate J Feline Med Surg 2005, 7:65-70. 10.1016/j.jfms.2004.08.005 15686976
73. Ly A Stamatatos L V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies J Virol 2000, 74:6769-6776. 112193 10888615 10.1128/JVI.74.15.6769-6776.2000
74. Chou PY Fasman GD Prediction of the secondary structure of proteins from their amino acid sequence Adv Enzymol Relat Areas Mol Biol 1978, 47:45-148. 364941
75. Leonard CK Spellman MW Riddle L Harris RJ Thomas JN Gregory TJ Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells J Biol Chem 1990, 265:10373-10382. 2355006
76. Pancino G Fossati I Chappey C Castelot S Hurtrel B Moraillon A Klatzmann D Sonigo P Structure and variations of feline immunodeficiency virus envelope glycoproteins. Virology 1993, 192:659-662. 10.1006/ viro.1993.1083 8380668
77. Henikoff S Henikoff JG Embedding strategies for effective use of information from multiple sequence alignments Protein Sci 1997, 6:698-705. 2143675 9070452
78. Srivastava IK VanDorsten K Vojtech L Barnett SW Stamatatos L Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable region J Virol 2003, 77:2310-2320. 141106 12551968 10.1128/ JVI.77.4.2310-2320.2003
79. Barnett SW Lu S Srivastava I Cherpelis S Gettie A Blanchard J Wang S Mboudjeka I Leung L Lian Y Fong A Buckner C Ly A Hilt S Ulmer J Wild CT Mascola JR Stamatatos L The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region J Virol 2001, 75:5526-5540. 114265 11356960 10.1128/JVI.75.12.5526-5540.2001
80. Willett BJ Hosie MJ Chemokine receptors and co-stimulatory molecules: Unravelling feline immunodeficiency virus infection Vet Immunol Immunopathol 2008, 123:56-64. 2413005 18289703 10.1016/ j.vetimm.2008.01.012
81. Willett BJ Cannon CA Hosie MJ Upregulation of surface feline CXCR4 expression following ectopic expression of CCR5: Implications for studies of the cell tropism of feline immunodeficiency virus J Virol 2002, 76:9242-9252. 136470 12186908 10.1128/JVI.76.18.9242-9252.2002
82. Hosie MJ Broere N Hesselgesser J Turner JD Hoxie JA Neil JC Willett BJ Modulation of feline immunodeficiency virus infection by stromal cell-derived factor (SDF-1). J Virol 1998, 72:2097-2104. 109504 9499065
83. de Parseval A Grant CK Sastry KJ Elder JH Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): Soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope J Virol 2006, 80:3088-3091. 1395450 16501119 10.1128/JVI.80.6.3088-3091.2006
84. de Parseval A Chatterji U Morris G Sun P Olson AJ Elder JH Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus Nat Struct Mol Biol 2004, 12:60-66. 10.1038/ nsmb872 15592478
85. deParseval A Elder JH Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: Role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor J Virol 2001, 75:4528-4539. 114206 11312323 10.1128/JVI.75.10.4528-4539.2001
86. Hesselgesser J HalksMiller M DelVecchio V Peiper SC Hoxie J Kolson DL Taub D Horuk R CD4-independent association between HIV-1 gp120 and CXCR4: Functional chemokine receptors are expressed in human neurons Current Biology 1997, 7:112-121. 10.1016/S0960-9822(06)00055-8 9024623
87. Bendinelli M Pistello M Del Mauro D Cammarota G Maggi F Leonildi A Giannecchini S Bergamini C Matteucci D During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein J Virol 2001, 75:4584-4593. 114211 11312328 10.1128/ JVI.75.10.4584-4593.2001
88. Li Y Cleveland B Klots I Travis B Richardson BA Anderson D Montefiori D Polacino P Hu SL Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses J Virol 2008, 82:638-651. 2224603 17959660 10.1128/JVI.01691-07
89. Siebelink KHJ Karlas JA Rimmelzwaan GF Osterhaus ADME Bosch ML A determinant of feline immunodeficiency virus involved in CrFK tropism. Vet Immunol Immunopathol 1995, 46:61-69. 10.1016/0165-2427(94)07006-S 7542413
90. Verschoor EJ Boven LA Blaak H van Vliet ARW Horzinek MC de Ronde A A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells. J Virol 1995, 69:4752-4757. 189284 7609041
91. Pastore C Nedellec R Ramos A Pontow S Ratner L Mosier DE Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations J Virol 2006, 80:750-758. 1346864 16378977 10.1128/JVI.80.2.750-758.2006
92. Ogert RA Lee MK Ross W Buckler-White A Martin MA Cho MW N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism J Virol 2001, 75:5998-6006. 114315 11390601 10.1128/JVI.75.13.5998-6006.2001
93. Ross TM Cullen BR The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop Proc Natl Acad Sci U S A 1998, 95:7682-7686. 22722 9636210 10.1073/pnas.95.13.7682
94. Rizzuto CD Wyatt R Hernandez-Ramos N Sun Y Kwong PD Hendrickson WA Sodroski J A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding Science 1998, 280:1949-1953. 10.1126/ science.280.5371.1949 9632396
95. Sparger EE Beebe AM Dua N Himathongkam S Elder JH Torten M Higgins J Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus Virology 1994, 205:546-553. 10.1006/ viro.1994.1677 7975256
96. Diehl LJ Mathiason-Dubard CK O'Neil LL Hoover EA Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR J Virol 1995, 69:2328-2332. 188904 7533856